Jonathan Birchall's Net Worth

-$13.6 Thousand

Estimate Recalculated Sep 8, 2024 07:33PM EST

Who is Jonathan Birchall?

Jonathan Birchall does not have any significant net worth to report based on the numbers we have. This is based on reported shares in PhaseBio Pharmaceuticals Inc.

SEC CIK

Jonathan Birchall's CIK is 0001892776

Past Insider Trading and Trends

2022 was Jonathan Birchall's most active year for acquiring shares with 3 total transactions. Jonathan Birchall's most active month to acquire stocks was the month of January. 2021 saw Jonathan Birchall paying a total of $842,500.00 for 250,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001

Chief Commercial Officer

Jonathan Birchall owns 20,000 units of Common Stock which is worth $0.02. In the year 2021 Jonathan Birchall filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
20K
$0.68
$13,626.00
20K
May 20
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
Nov 8
Form 3
—
0
—
—
0
No matching records found